Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction

Documents similaires

• Association between patient‐reported eating behaviours and weight change: Secondary analyses of a randomized, double‐blind trial comparing retatrutide and placebo in people with obesity or overweight
  par: Chisom Kanu, et autres
  Publié: (2025)
• Decreases in circulating ANGPTL3 /8 concentrations following retatrutide treatment parallel reductions in serum lipids
  par: Yi Wen, et autres
  Publié: (2025)
• Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )
  par: Lauren Wilson, et autres
  Publié: (2026)
• Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
  par: Scott A. Coon, et autres
  Publié: (2025)
• Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept
  par: Shobha Bhattachar, et autres
  Publié: (2026)